Japan Specialist

Mark Chadwick

Over 20 years experience in equities and asset management in Asia and Japan. Qualified CFA with experience analyzing companies as a buy-side analyst. In-depth knowledge of company fundamental analysis, corporate governance and valuations.

Thematic (Sector/Industry)

Japan Consumer discretionary / Thematic (Sector/Industry)

<ul>
<li>Japanese equities ended the week firmer, with Topix advancing +1%, lifting YTD gains to +11.5%</li>
<li>Among individual stocks, Sumi Pharma surged +18% and Eisai jumped +13% on strong product news, while Nidec slumped -21% amid continued accounting scandal headlines</li>
<li>Political risks rising: The LDP will decide next week whether to move forward with an early presidential vote.</li>
</ul>


Japanese equities ended the week firmer, with Topix advancing +1%, lifting YTD gains to +11.5%
Among individual stocks, Sumi Pharma surged +18% and Eisai jumped +13% on strong product news, while Nidec slumped -21% amid continued accounting scandal headlines
Political risks rising: The LDP will decide next week whether to move forward with an early presidential vote.


日本戦略ウィークリー | 株価は上昇するも、政治的な暗雲が立ち込める